Peptides and Obesity: Evaluating Intranasal Administration of Peptides for Therapeutic Potential

ABSTRACT Obesity is a complex global health issue characterized by an imbalance in energy homeostasis and associated with significant health risks, including cardiovascular diseases, diabetes, and cancer. While various therapeutic approaches exist, peptide‐based treatments have emerged as promising candidates due to their specificity and reduced side effects. Because many of the mechanisms are centrally regulated in the brain, effective intervention requires peptides with good brain penetration or alternative delivery strategies. In this context, this review explores the potential of intranasal delivery of therapeutic peptide candidates for obesity management, highlighting its advantages in bypassing the blood–brain barrier, targeting central pathways regulating appetite and energy expenditure, and minimizing systemic exposure, while also considering the translational limitations of this delivery route. The review analyses established and emerging peptides, including leptin, GLP‐1 analogs, and oxytocin, focusing on their central mechanisms of action, specifically their ability to target the brain. It highlights how these peptides regulate energy homeostasis, appetite, and metabolism through direct activation of neural circuits in the hypothalamus, brainstem, and other key regions involved in obesity management. Furthermore, it evaluates the prospects of intranasal peptide therapeutics as an innovative strategy in obesity treatment, addressing both the opportunities and limitations in the context of clinical and preclinical evidence. Continued research and technological advancements are essential to optimize peptide formulations and delivery systems, ensuring efficacy, safety, and patient compliance in combating the obesity epidemic.

Authors

Institutions

Publication Details

Journal
Obesity Reviews
Published
2026-11-16
DOI
https://doi.org/10.1111/obr.70259
Primary Topic
Regulation of Appetite and Obesity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Peptides and Obesity: Evaluating Intranasal Administration of Peptides for Therapeutic Potential

Jérôme Leprince, Sergueı̈ O. Fetissov, Marie-Anne Le Solliec, Marie Picot et al.
Obesity Reviews
Regulation of Appetite and Obesity
article

Peptides and Obesity: Evaluating Intranasal Administration of Peptides for Therapeutic Potential

Jérôme Leprince, Sergueı̈ O. Fetissov, Marie-Anne Le Solliec, Marie Picot, Jean Albert Boutin, Benjamin Lefranc, Karthi Duraisamy, Gaëtan Prévost, Olfa Masmoudi‐Kouki, Amine Bourzam, Omayma Dlimi, nicolas chartrel
article en

Abstract

ABSTRACT Obesity is a complex global health issue characterized by an imbalance in energy homeostasis and associated with significant health risks, including cardiovascular diseases, diabetes, and cancer. While various therapeutic approaches exist, peptide‐based treatments have emerged as promising candidates due to their specificity and reduced side effects. Because many of the mechanisms are centrally regulated in the brain, effective intervention requires peptides with good brain penetration or alternative delivery strategies. In this context, this review explores the potential of intranasal delivery of therapeutic peptide candidates for obesity management, highlighting its advantages in bypassing the blood–brain barrier, targeting central pathways regulating appetite and energy expenditure, and minimizing systemic exposure, while also considering the translational limitations of this delivery route. The review analyses established and emerging peptides, including leptin, GLP‐1 analogs, and oxytocin, focusing on their central mechanisms of action, specifically their ability to target the brain. It highlights how these peptides regulate energy homeostasis, appetite, and metabolism through direct activation of neural circuits in the hypothalamus, brainstem, and other key regions involved in obesity management. Furthermore, it evaluates the prospects of intranasal peptide therapeutics as an innovative strategy in obesity treatment, addressing both the opportunities and limitations in the context of clinical and preclinical evidence. Continued research and technological advancements are essential to optimize peptide formulations and delivery systems, ensuring efficacy, safety, and patient compliance in combating the obesity epidemic.

Obesity Reviews
Tunis University (TN), Inserm (FR), Normandie Université (FR), Université de Rouen Normandie (FR), Tunis El Manar University (TN)
Regulation of Appetite and Obesity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon